Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from Operating Activities:
Net loss	$ (136,065,000)	$ (120,063,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	10,141,000	11,977,000
Provision for bad debts	11,129,000	9,915,000
Stock-based compensation	9,127,000	11,468,000
Compensation expense related to share repurchase and shareholder note settlement	12,846,000
Gain on extinguishment of debt		(7,017,000)
Change in fair value - convertible instrument liability	(93,029,000)	5,383,000
Change in fair value - warrant liability	31,749,000	15,353,000
Non-cash interest expense	1,897,000	6,000
Non-cash lease expense	955,000
Amortization of debt issuance costs	4,609,000	978,000
Amortization of stock transfer agreement	148,000
Loss (gain) from disposal of property and equipment	6,000	(11,000)
Impairment loss on goodwill	23,269,000	0
Impairment loss on long-lived assets		838,000
Loss (gain) from foreign currency remeasurement	58,000	78,000
Transaction costs	17,640,000
Net changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(9,820,000)	(9,144,000)
Prepaid expenses and other current assets	(463,000)	(1,388,000)
Operating leases liabilities	(1,607,000)
Other assets	(3,247,000)	149,000
Accounts payable	(1,517,000)	3,721,000
Accrued host payments and insurance fees	(972,000)	2,137,000
Accrued expenses and other liabilities	(9,083,000)	(4,806,000)
Deferred taxes	(685,000)	(480,000)
Deferred revenue	385,000	(140,000)
Net Cash Used in Operating Activities	(132,529,000)	(81,046,000)
Cash flows from Investing Activities:
Investment in intangible assets	(1,094,000)
Purchases of property and equipment	(2,257,000)	(1,505,000)
Proceeds from sale of property and equipment		414,000
Net Cash Used in Investing Activities	(3,351,000)	(1,091,000)
Cash flows from Financing Activities:
Proceeds from exercise of common stock options	166,000	1,352,000
Proceeds from Issuance of Series E, net of $26 issuance costs		616,000
Proceeds from Issuance of Series E-2 warrants		912,000
Proceeds from issuance of Subordinated Convertible Promissory Note		29,420,000
Proceeds from exercise of Series E-3 Warrants		1,000
Proceeds from Deutsche Bank loan, net of $607 issuance costs and $675 debt discount		73,718,000
Proceeds from issuance of Mudrick Convertible Promissory Notes and warrants, net of issuance costs	169,750,000
Proceeds from issuance of Bridge Loans	30,770,000
Related Party advance on financing	4,750,000
Proceeds from Braemar Subordinated Promissory Note	2,000,000
Proceeds from the recapitalization of Getaround shares, (net of redemptions and InterPrivate II Acquisition Corp. prior incurred costs)	15,668,000
Repayment of Horizon loan		(25,000,000)
Repayment of Deutsche Bank Loan	(75,000,000)
Deutsche Bank loan repayment and extinguishment fees, including accrued but unpaid interest	(4,331,000)
Repayment of PGE loan	(302,000)	(177,000)
Repurchase of shares from related party	(5,313,000)
Horizon loan repayment and extinguishment fees		(1,875,000)
Proceeds from issuance of notes payable, net of $2 issuance costs		6,998,000
Net Cash Provided by Financing Activities	138,158,000	85,965,000
Effect of Foreign Currency Translation on Cash	(850,000)	(1,641,000)
Net change in cash and cash equivalents and restricted cash and cash equivalents	1,428,000	2,187,000
Cash and Cash Equivalents and Restricted Cash, beginning of year	66,466,000	64,279,000
Cash and Cash Equivalents and Restricted Cash, end of year	67,894,000	66,466,000
Cash paid for:
Cash paid for interest	6,508,000	6,392,000
Non-cash investing and financing activities:
Exercise of Series E-3 Preferred stock warrants into Series E-3 convertible redeemable preferred stock	408,000	3,213,000
Exercise of Series E-2 Preferred stock warrants into Series E-2 convertible redeemable preferred stock		301,000
Property and equipment unpaid at period end		72,000
Issuance of common stock to settle liability settlement		1,099,000
Receivable at period end from exercise of common stock options		13,000
Exercise of Series B preferred stock warrants into Series B convertible redeemable preferred stock	240,000
Conversion of convertible promissory notes and bridge Loans to common Stock	89,136,000
Issuance of Braemar stock transfer agreement (debt discount on Braemar Subordinated Promissory Note)	1,498,000
Warrant conversion to common stock due to Business Combination	81,303,000
Incremental guarantee commission owed to PGE Lender	53,000
Conversion of iHeart Media Note Payable to Common Stock	388,000
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	64,294,000	62,516,000
Restricted cash included in current assets	3,600,000	3,950,000
Total Cash, Cash Equivalents and Restricted Cash at the End of Year	$ 67,894,000	$ 66,466,000